Prof. Stephen J. Schuster | ICML 2017 | Interim results of the JULIET trial of CTL019 in R/R DLBCL

Interim results of the JULIET trial of CTL019 in R/R DLBCL

EBMT Debate Session | How to treat R/R DLBCL in 2019? | Part 3 – CAR-T

A Keynote Debate Session on how to treat patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) took...

EHA 2018 | Updated results from the phase II JULIET trial of tisagenlecleucel in patients with R/R DLBCL

EHA 2018 | Updated results from the phase II JULIET trial of tisagenlecleucel in patients with...

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox every month

First Name

Last Name

I agree to the Lymphoma Hub Terms & Conditions